<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1222</ReferenceId>
        <DateLastUpdated>2011-08-23-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15919103</PubmedId>
            <Abstract>Human monoclonal antibody fragments neutralizing wild-type and vaccine strains of yellow fever (YF) virus (genotypes West Africa I + II, East/Central Africa, 17D-204-WHO) were generated by repertoire cloning from YF patients. Analysis of virus escape variants identified amino acid (aa) 71 in domain II of the envelope glycoprotein (E) as the most critical residue for neutralization, with aa 153-155 in domain I contributing to the epitope. These data confirm the previous mapping of YFV neutralizing epitopes using mouse monoclonal antibodies but suggest that a conformational epitope could be formed by amino acids from domains I and II opposing each other in the dimeric form of the E protein. While the sera of the YF patients showed up to 10-fold reduced neutralizing activity against the 17D escape variants, sera from 17D vaccinees retained their neutralizing titers. Mutations in this major neutralizing epitope of YFV thus do not seem to carry the risk of immune escape in persons immunized with the YFV-17D vaccine.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>262-72</ArticlePages>
            <ArticleTitle>Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Daffis</LastName>
                    <ForeName>Stephane</ForeName>
                </Author>
                <Author>
                    <LastName>Kontermann</LastName>
                    <ForeName>Roland E</ForeName>
                </Author>
                <Author>
                    <LastName>Korimbocus</LastName>
                    <ForeName>Jehanara</ForeName>
                </Author>
                <Author>
                    <LastName>Zeller</LastName>
                    <ForeName>Hervé</ForeName>
                </Author>
                <Author>
                    <LastName>Klenk</LastName>
                    <ForeName>Hans-Dieter</ForeName>
                </Author>
                <Author>
                    <LastName>Ter Meulen</LastName>
                    <ForeName>Jan</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institut für Virologie, Philipps-Universität, Robert-Koch-Strasse 17, 35037 Marburg, Germany. daffis@mailer.uni-marburg.de</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antibodies, Viral;Gene Products, env;Immunoglobulin Heavy Chains;Immunoglobulin Light Chains;Peptide Fragments;Viral Matrix Proteins;Yellow Fever Vaccine</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Antibodies, Monoclonal(analysis; genetics); Antibodies, Viral(analysis; chemistry; genetics); Antibody Formation; Gene Products, env(chemistry; genetics; immunology); Genetic Variation; Humans; Immunoglobulin Heavy Chains(chemistry); Immunoglobulin Light Chains(chemistry); Models, Molecular; Molecular Sequence Data; Neutralization Tests; Peptide Fragments(immunology); Protein Conformation; Viral Matrix Proteins(chemistry; genetics; immunology); Yellow Fever Vaccine(immunology); Yellow fever virus(genetics; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>337</Volume>
                <Issue>2</Issue>
                <Title>Virology</Title>
                <Issn>0042-6822</Issn>
                <MedlineTa>Virology</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>7A</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>N71, T153, T154, D155</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>61651985</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>617102</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1 and p. 5</LocationOfData>
                <EpitopeId>110511</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2A</LocationOfData>
                        <BCellId>17848</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:9682</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11089</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Yellow fever virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Single-chain antibodies (scFv) were constructed by repertoire cloning from yellow fever patients and panned with yellow fever virus 17D virions.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In addition to neutralizaing the yellow fever virus 17D-204-WHO vaccine strain, the single-chain antibody scFv-7A was able to neutralize the wild-type yellow fever strains Asibi, Nigeria87, Ethiopia61, CAR86 and Senegal 90. The strain Senegal 1990 was neutralized four to 10-fold less efficiently than all the other strains and differs from Asibi by an N153K mutation and three additional mutations (T7A, A54V, N249D) in the envelope. The critical residues for neutralization were identified by sequencing escape mutants that were resistant to neutralizaation by single chain antibody scFv-7A. Amino acid N71 was the most critical residue for neutralization.  Using the published crystal structure of the closely related dengue virus type 2 glycoprotein E to model the structure of the yellow fever virus E protein, it was found that all the critical residues could form a neutralizaing epitope in an E protein homodimer of antiparallel orientation.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>scFv-7A</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Yellow fever virus 17D</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>617102</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>17875</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:9682</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11089</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Yellow fever virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Single-chain antibodies (scFv) were constructed by repertoire cloning from yellow fever patients and panned with yellow fever virus 17D virions.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>308</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>In a competition ELISA using biotinylated single-chain antibody scFV-7A, this antibody fragment competed for binding to yellow fever virus 17-D virions with the other neutralizing antibody fragments scFv-5A, scFv-R3(27) and scFv-R3(9) suggesting that all of the antibodies that neutralize scFv bind to the same or to a closely related conformational epitope on the envelope protein.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>scFv-7A</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Yellow fever virus 17D</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>617102</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4B</LocationOfData>
                        <BCellId>17849</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:9682</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11089</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Yellow fever virus</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Single-chain antibodies (scFv) were constructed by repertoire cloning from yellow fever patients and panned with yellow fever virus 17D virions.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>39</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>From a mixture of soluble yellow fever virus proteins, the single-chain antibody scFv-7A was able to precipitate a 55-kDa protein with the molecular weight expected for the yellow fever virus envelope glycoprotein.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>scFv</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>scFv-7A</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>polyprotein precursor</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>61651985</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>617102</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

